Haleon plc (NYSE:HLN – Get Free Report) saw a significant growth in short interest in the month of January. As of January 15th, there was short interest totalling 18,140,000 shares, a growth of 6.8% from the December 31st total of 16,990,000 shares. Approximately 0.4% of the company’s shares are short sold. Based on an average daily volume of 6,580,000 shares, the short-interest ratio is presently 2.8 days.
Wall Street Analyst Weigh In
A number of equities analysts have recently commented on HLN shares. Morgan Stanley downgraded Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday, January 10th. Sanford C. Bernstein downgraded Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Three research analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $10.95.
Check Out Our Latest Report on Haleon
Haleon Stock Up 0.4 %
Hedge Funds Weigh In On Haleon
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Dimensional Fund Advisors LP lifted its stake in Haleon by 2.5% in the second quarter. Dimensional Fund Advisors LP now owns 1,007,458 shares of the company’s stock valued at $8,322,000 after buying an additional 24,673 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its stake in Haleon by 12.3% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 13,281 shares of the company’s stock valued at $110,000 after buying an additional 1,450 shares during the last quarter. Truist Financial Corp raised its stake in shares of Haleon by 4.9% during the second quarter. Truist Financial Corp now owns 757,133 shares of the company’s stock worth $6,254,000 after purchasing an additional 35,456 shares during the last quarter. Sanctuary Advisors LLC purchased a new stake in shares of Haleon during the second quarter worth approximately $1,658,000. Finally, GAMMA Investing LLC raised its stake in shares of Haleon by 49.7% during the third quarter. GAMMA Investing LLC now owns 15,043 shares of the company’s stock worth $159,000 after purchasing an additional 4,992 shares during the last quarter. 6.67% of the stock is owned by institutional investors and hedge funds.
About Haleon
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
See Also
- Five stocks we like better than Haleon
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Conference Calls and Individual Investors
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
- Stock Market Upgrades: What Are They?
- High-Yield Dividend King PepsiCo Offers Value Too Good to Ignore
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.